SineuGene Therapeutics Reports the US FDA’s IND Clearance of SNUG01 for Amyotrophic Lateral Sclerosis
Shots: The US FDA has granted IND clearance to SNUG01 for ALS SNUG...
Sanofi Reports the US FDA’s Acceptance & Priority Review of Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosi...
Shots: The US FDA has accepted NDA & granted priority review to tolebrutinib f...
GSK Reports the EMA’s Acceptance of Nucala (Mepolizumab) as an Add-on Treatment for COPD
Shots: The EMA has accepted label expansion application of Nucala as an add-on mai...
China’s NMPA Approves Junshi Biosciences’ Toripalimab + Bevacizumab for Advanced Hepatocellular Carcinoma
Shots: China’s NMPA has approved sBLA of toripalimab + bevacizumab for the 1...
HUTCHMED Receives NMPA’s Conditional Approval for Tazverik to Treat R/R Follicular Lymphoma
Shots: China’s NMPA has granted conditional approval to Tazverik for the tre...
Johnson & Johnson Reports the US FDA’s Approval of Subcutaneous & Intravenous Tremfya for Active Crohn’s Disease (CD)
Shots: Approval was based on P-III trials, incl.
